Cargando…

Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos

BACKGROUND: Insulin resistance (IR) is a state prior to the development of type 2 diabetes (T2D) and it is reversible with lifestyle modification. However, it is underdiagnosed due to the difficulty in its measurement. OBJECTIVE: To evaluate the diagnostic performance of the FINDRISC questionnaire t...

Descripción completa

Detalles Bibliográficos
Autores principales: Varela-Vega, Yuline, Roy-García, Ivonne Analí, Pérez-Rodríguez, Marcela, Velázquez-López, Lubia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Mexicano del Seguro Social 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395935/
https://www.ncbi.nlm.nih.gov/pubmed/36542467
_version_ 1785083690048552960
author Varela-Vega, Yuline
Roy-García, Ivonne Analí
Pérez-Rodríguez, Marcela
Velázquez-López, Lubia
author_facet Varela-Vega, Yuline
Roy-García, Ivonne Analí
Pérez-Rodríguez, Marcela
Velázquez-López, Lubia
author_sort Varela-Vega, Yuline
collection PubMed
description BACKGROUND: Insulin resistance (IR) is a state prior to the development of type 2 diabetes (T2D) and it is reversible with lifestyle modification. However, it is underdiagnosed due to the difficulty in its measurement. OBJECTIVE: To evaluate the diagnostic performance of the FINDRISC questionnaire to identify IR. MATERIAL AND METHODS: An analytical cross-sectional study was performed in adults aged 20 to 60 years without previous diagnosis of T2D. Those using steroids and pregnant women were excluded. IR was diagnosed through the Triglycerides/glucose index. A ROC curve was used to establish the cut-off point for the diagnosis of IR. Sensitivity, specificity, predictive values and likelihood ratios were calculated. Risk measurement for IR was performed with the FINDRISC instrument. RESULTS: A total of 253 participants were included, with a prevalence of IR of 60.8%. The area under the curve of the FINDRISC instrument was 0.813 (95% confidence interval [95% CI] 0.759-0.865), with a cut-off point of 8. Sensitivity was 94.8% and specificity was 48.5%, positive predictive value was 74% and negative 86%, with a positive likelihood ratio of 1.84 and a negative of 0.11. CONCLUSIONS: The FINDRISC instrument is a useful screening tool to identify subjects with IR at the first level of care. A score ≥ 8 identifies subjects with IR
format Online
Article
Text
id pubmed-10395935
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Instituto Mexicano del Seguro Social
record_format MEDLINE/PubMed
spelling pubmed-103959352023-08-04 Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos Varela-Vega, Yuline Roy-García, Ivonne Analí Pérez-Rodríguez, Marcela Velázquez-López, Lubia Rev Med Inst Mex Seguro Soc Aportación Original BACKGROUND: Insulin resistance (IR) is a state prior to the development of type 2 diabetes (T2D) and it is reversible with lifestyle modification. However, it is underdiagnosed due to the difficulty in its measurement. OBJECTIVE: To evaluate the diagnostic performance of the FINDRISC questionnaire to identify IR. MATERIAL AND METHODS: An analytical cross-sectional study was performed in adults aged 20 to 60 years without previous diagnosis of T2D. Those using steroids and pregnant women were excluded. IR was diagnosed through the Triglycerides/glucose index. A ROC curve was used to establish the cut-off point for the diagnosis of IR. Sensitivity, specificity, predictive values and likelihood ratios were calculated. Risk measurement for IR was performed with the FINDRISC instrument. RESULTS: A total of 253 participants were included, with a prevalence of IR of 60.8%. The area under the curve of the FINDRISC instrument was 0.813 (95% confidence interval [95% CI] 0.759-0.865), with a cut-off point of 8. Sensitivity was 94.8% and specificity was 48.5%, positive predictive value was 74% and negative 86%, with a positive likelihood ratio of 1.84 and a negative of 0.11. CONCLUSIONS: The FINDRISC instrument is a useful screening tool to identify subjects with IR at the first level of care. A score ≥ 8 identifies subjects with IR Instituto Mexicano del Seguro Social 2023 /pmc/articles/PMC10395935/ /pubmed/36542467 Text en © 2023 Revista Médica del Instituto Mexicano del Seguro Social. https://creativecommons.org/licenses/by-nc-nd/4.0/Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivar 4.0 Internacional.
spellingShingle Aportación Original
Varela-Vega, Yuline
Roy-García, Ivonne Analí
Pérez-Rodríguez, Marcela
Velázquez-López, Lubia
Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos
title Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos
title_full Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos
title_fullStr Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos
title_full_unstemmed Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos
title_short Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos
title_sort certeza diagnóstica del instrumento findrisc para identificar resistencia a la insulina en adultos
topic Aportación Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395935/
https://www.ncbi.nlm.nih.gov/pubmed/36542467
work_keys_str_mv AT varelavegayuline certezadiagnosticadelinstrumentofindriscparaidentificarresistenciaalainsulinaenadultos
AT roygarciaivonneanali certezadiagnosticadelinstrumentofindriscparaidentificarresistenciaalainsulinaenadultos
AT perezrodriguezmarcela certezadiagnosticadelinstrumentofindriscparaidentificarresistenciaalainsulinaenadultos
AT velazquezlopezlubia certezadiagnosticadelinstrumentofindriscparaidentificarresistenciaalainsulinaenadultos